JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was THB 106.28 million compared to THB 107.24 million a year ago. Net loss was THB 4.71 million compared to net income of THB 6.32 million a year ago. Basic loss per share from continuing operations was THB 0.01 compared to basic earnings per share from continuing operations of THB 0.02 a year ago. Diluted loss per share from continuing operations was THB 0.01 compared to diluted earnings per share from continuing operations of THB 0.02 a year ago.
For the nine months, revenue was THB 291.41 million compared to THB 316.78 million a year ago. Net loss was THB 28.14 million compared to net income of THB 25.69 million a year ago. Basic loss per share from continuing operations was THB 0.06 compared to basic earnings per share from continuing operations of THB 0.08 a year ago. Diluted loss per share from continuing operations was THB 0.06 compared to diluted earnings per share from continuing operations of THB 0.08 a year ago.